Q3 2023 Holdings
Filed 2023-11-14 | 42 holdings | $549.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Urogen Pharma LTD(URGN) | COM | M96088105 | $36.7M | 2,620,545 | 6.7% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $35.3M | 3,078,633 | 6.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $30.4M | 1,755,184 | 5.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $27.1M | 531,211 | 4.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $25.9M | 727,426 | 4.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $24.5M | 875,044 | 4.5% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $24.2M | 1,458,070 | 4.4% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $21.7M | 3,295,000 | 4.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $20.0M | 165,200 | 3.6% |
| Evolus Inc(EOLS) | COM | 30052C107 | $20.0M | 2,186,934 | 3.6% |
| Point Biopharma Global Inc | COM | 730541109 | $19.4M | 2,909,960 | 3.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $17.7M | 600,000 | 3.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $17.1M | 500,001 | 3.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $16.1M | 894,333 | 2.9% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $15.1M | 290,917 | 2.8% |
| Aerovate Therapeutics Inc | COM | 008064107 | $14.8M | 1,091,233 | 2.7% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $11.7M | 225,000 | 2.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $11.6M | 1,691,768 | 2.1% |
| Sarepta Therapeutics Inc(SRPT)Put | COM | 803607100 | $11.5M | 95,000 | 2.1% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $11.2M | 500,000 | 2.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $10.9M | 638,495 | 2.0% |
| Optinose Inc | COM | 68404V100 | $10.9M | 8,839,939 | 2.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $10.4M | 857,000 | 1.9% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $10.3M | 287,500 | 1.9% |
| Karuna Therapeutics Inc | COM | 48576A100 | $10.2M | 60,500 | 1.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $10.0M | 198,500 | 1.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $10.0M | 394,872 | 1.8% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $8.9M | 1,167,061 | 1.6% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $8.5M | 400,000 | 1.6% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $5.2M | 6,230,272 | 0.9% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $5.1M | 615,317 | 0.9% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $4.9M | 4,737,368 | 0.9% |
| Aclaris Therapeutics Inc(ACRS)Call | COM | 00461U105 | $4.8M | 700,000 | 0.9% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $4.7M | 215,000 | 0.9% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $4.5M | 1,074,101 | 0.8% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $3.9M | 1,022,537 | 0.7% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $3.8M | 86,302 | 0.7% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $3.2M | 645,899 | 0.6% |
| Talaris Therapeutics Inc | COM | 87410C104 | $2.8M | 1,000,000 | 0.5% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $1.7M | 579,667 | 0.3% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $1.1M | 450,403 | 0.2% |
| Ambrx Biopharma IncCall | SPONSORED ADS | 02290A102 | $1.1M | 97,700 | 0.2% |